Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.81143 | 74 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.79237 | 74 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.28747 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.07815 | 75 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.83677 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.64392 | 73 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.79563 | 74 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.04956 | 76 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.12882 | 76 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.82734 | 74 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.48188 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.76625 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.40777 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.11955 | 76 |